[
  {
    "ts": null,
    "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update",
    "summary": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update",
    "url": "https://finnhub.io/api/news?id=e6e4798152e96670c0503e9df9c92123ac01373baf6237c77d912a394a502444",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770850555,
      "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update",
      "id": 139052262,
      "image": "",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e6e4798152e96670c0503e9df9c92123ac01373baf6237c77d912a394a502444"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=032162f848fff3fe187c8963286e150d4584aa308059d48651d7021547f4dcb8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770827640,
      "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "id": 139060021,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=032162f848fff3fe187c8963286e150d4584aa308059d48651d7021547f4dcb8"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish?",
    "summary": "Although Thermo Fisher Scientific has underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=1660dce169305badbf2ce27c9135f352088db8ca9671d6ed090878f028534763",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770823411,
      "headline": "Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish?",
      "id": 139048078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Although Thermo Fisher Scientific has underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=1660dce169305badbf2ce27c9135f352088db8ca9671d6ed090878f028534763"
    }
  },
  {
    "ts": null,
    "headline": "Insiders At Thermo Fisher Scientific Sold US$3.6m In Stock, Alluding To Potential Weakness",
    "summary": "Many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders ditched their stock over the past year, which may be of...",
    "url": "https://finnhub.io/api/news?id=f8b6f1d9d4930ffaa9100e0346e7fadfcac1cdbc36084e677c75b9737d0bb2f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770818418,
      "headline": "Insiders At Thermo Fisher Scientific Sold US$3.6m In Stock, Alluding To Potential Weakness",
      "id": 139045136,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders ditched their stock over the past year, which may be of...",
      "url": "https://finnhub.io/api/news?id=f8b6f1d9d4930ffaa9100e0346e7fadfcac1cdbc36084e677c75b9737d0bb2f5"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant",
    "summary": "WALTHAM, Mass., February 11, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and biotech companies to connect real-world data with clinical research—helping them generate stronger evidence, faster.",
    "url": "https://finnhub.io/api/news?id=a826daac268f54747c22ca7cb930472593cc94cf8b11dbe6ea7fe06c1563f4b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770815700,
      "headline": "Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant",
      "id": 139042305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., February 11, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and biotech companies to connect real-world data with clinical research—helping them generate stronger evidence, faster.",
      "url": "https://finnhub.io/api/news?id=a826daac268f54747c22ca7cb930472593cc94cf8b11dbe6ea7fe06c1563f4b5"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cell Therapy Raw Materials Market size & share revenue was valued at approximately USD 5.2 Billion in 2025 and is expected to reach USD 6.1 Billion in 2026 and is expected to reach around USD 29.3 Billion by 2035, at a CAGR of 18.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientifi",
    "url": "https://finnhub.io/api/news?id=c22cd33e3631ef80746530b35aceb063fc0500a94ebd206fe4f30c49608849e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770798600,
      "headline": "[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 139040455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cell Therapy Raw Materials Market size & share revenue was valued at approximately USD 5.2 Billion in 2025 and is expected to reach USD 6.1 Billion in 2026 and is expected to reach around USD 29.3 Billion by 2035, at a CAGR of 18.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientifi",
      "url": "https://finnhub.io/api/news?id=c22cd33e3631ef80746530b35aceb063fc0500a94ebd206fe4f30c49608849e9"
    }
  }
]